Ayse Oktem

Ayse Oktem

Auto-generated profile, based on publicly available information

Ayse Oktem

Ankara University Faculty of Medicine, Department of Dermatology, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2016 in Journal of Dermatological Treatment
Verified
Journal Article
Closed access
AOAyse Oktem
Ayse Oktem
BABengu Nisa Nisa Akay
Bengu Nisa Nisa Akay
ABAyse Boyvat
Ayse Boyvat
NKNihal Kundakci
Nihal Kundakci
CECengizhan Erdem
Cengizhan Erdem
PKPelin Kocyigit
Pelin Kocyigit
Background: Epidermolysis bullosa acquisita (EBA) is a rare subepidermal bullous disease. Long-term remission in this disease is difficult using current treatments, unlike that in patients with other autoimmune bullous diseases. Objective: We retrospectively evaluated the effectiveness and side effects of rituximab–intravenous immunoglobulin (IVIg) combination treatment in five patients with EBA resistant to conventional treatment. Patients and methods: Rituximab (375 mg/m2) was administered for four consecutive weeks to four patients, and their treatment continued with IVIg at a dose of 2 g/kg/month. One patient received two cycles of rituximab for three consecutive weeks, IVIg in the fourth week, followed by monthly IVIg administrations as in the other patients. Results: The total number of IVIg therapy cycles ranged from 10 to 26 (mean 19.4). Mean skin involvement, mucosal involvement, and disease severity scores decreased after a mean follow-up of 22.6 months (range, 10–28 months). In an analysis performed during months 24–28, the number of CD19-positive B cells was found to be below the normal reference range in four patients. Limitations: This was a retrospective study with a limited number of patients. Conclusion: Rituximab–IVIg combination treatment seems to be effective and safe for treating patients with EBA resistant to conventional treatments.

1 November 2019 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PUPinar Incel Uysal
Pinar Incel Uysal
NANeslihan Akdogan
Neslihan Akdogan
YHYildiz Hayran
Yildiz Hayran
AOAyse Oktem
Ayse Oktem
BYBasak Yalcin
Basak Yalcin
Rosacea may result in emotional distress and anxiety. However, data on the presence of generalized anxiety disorder in rosacea patients are scarce. The aim of the study was to detect the frequency and level of anxiety and depression in patients with rosacea. A total of 194 consecutive rosacea patients and 194 age- and sex-matched controls were enrolled. Severity of rosacea was assessed in patients according to the criteria of the National Rosacea Society Ethics Committee. Both patients and controls were evaluated by the Generalized Anxiety Disorder 7-item scale, and severity was measured by the Generalized Anxiety Disorder-Adult. Individuals who were diagnosed with an anxiety and/or depressive disorder were more common in patient group (24.7% vs. 7.2%, p<0,01). Female patients were particularly at risk for having generalized anxiety disorder (OR=2.8; 95% CI 1.15-7.37; p=0.02). Single center study and limited sample size. Rosacea patients show greater risk of having anxiety disorders, including generalized anxiety disorder. Female patients, those with lower educational levels, those with phymatous subtype, untreated patients, and patients with prior psychiatric morbidity may be at particular risk for anxiety. It is essential to consider the psychological characteristics of patients to improve their well-being.

7 May 2019 in Journal of Dermatological Treatment
Verified
Journal Article
Closed access
AÖAyşe Öktem
Ayşe Öktem
YHYıldız Hayran
Yıldız Hayran
EAEsra Arı
Esra Arı
BYBaşak Yalçın
Başak Yalçın
Backround: Despite extensive usage of systemic isotretinoin in patients with acne for many years, laboratory monitoring protocols for adverse effects depend on the centers and there is no standardized practice for frequency and type of laboratory testing. We aimed to decrease unnecessary monitoring and to standardize our general clinical practice of our department as well as to provide patient comfort and cost saving. Material and Method: The medical charts of 704 acne patients treated with systemic isotretinoin were reviewed retrospectively. The National Cancer Institute common terminology criteria for adverse events v3.0 grading system was used in order to categorize the laboratory abnormalities of liver functions and lipid levels. Results: All laboratory abnormalities were grade I. Abnormal liver function was seen in 7.2% of the patients (n = 51), maximum values were ALT: 87 IU/L, AST: 97 IU/L (normal values, ALT: 5-41 IU/L, AST: 5-40 IU/L) and median time of the abnormalities in liver function tests was in the second month. Lipid profile abnormalities were detected in 58% of the patients (n = 401). Maximum values during the laboratory monitoring were Tg: 481mg/dL CHOL: 314mg/dL, LDL: 259 mg/dL (normal values, Tg:0-200 mg/dL, CHOL.: 0-200mg/dL, LDL: 0-100 mg/dL). The median time of lipid abnormalities was in the first month (1-3 months). Abnormalities related to CBC were seen in 8.2% of the patients (n = 58). The median time of CBC abnormality was the second month of treatment. Anemia, leukopenia and thrombocytopenia were seen in 3.4%, 3.7%, and 1.6% of the patients respectively. Conclusion: Clinically insignificant and revers CBC abnormalities, mild to moderate elevation of liver transaminases and serum lipids are the most common laboratory abnormalities in patients with acne treated with oral isotretinoin. Due to these abnormalities are reversible even the isotretinoin therapy continued, and generally there is no need to discontinuation of treatment due to laboratory abnormalities, frequent biochemical monitoring is not recommended.

13 July 2021 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
SVSeçil Vural
Seçil Vural
KKK. Kerl
K. Kerl
PDP. Ertop Doğan
P. Ertop Doğan
SVS. Vollmer
S. Vollmer
UPU. Puchta
U. Puchta
AAAkiko Arakawa
Akiko Arakawa
Background Behçet's disease (BD) presents with lymphocytic and neutrophilic vasculitis of unknown aetiology. HLA-B*51 ERAP1 and IL12R/IL23R are genetic risk factors. IL-23 regulates IL-17A, which controls recruitment and activation of neutrophils. Objectives To determine pathological changes in BD skin lesions related to the complex genetic predisposition Methods We characterised the expression of IL-17A and IL-23A in various cell types by immunohistological double staining of sections from papulopustular skin lesions (PPL) of acute attacks of BD and lesions of psoriasis vulgaris (PV), another HLA-class I-associated T-cell mediated autoimmune disease in which excessive T-cell derived IL-17A production promotes neutrophil activation. Results We found that in BD lesions, as in psoriasis, actively expanding CD8+ T cells were the predominant source of IL-17A. IL-17A+ CD8+ T (Tc17) cells outnumbered infiltrating IL-17A+ CD4+ T cells. Unlike the epidermal localisation of CD8+ T cells in psoriasis, Tc17 cells in BD lesions infiltrated mainly the perivascular tissue and also the blood vessel walls of dermis and subcutaneous tissue. They colocalised with a marked IL-23A expression by CD11c+ dendritic cells (DCs) and CD68+ macrophages. IL-17A expression was associated with extensive recruitment of neutrophils around blood vessels that formed neutrophil extracellular traps (NETs). Conclusions In BD, the genetic predisposition may mediate antigen-specific activation and differentiation of a Tc17 response, possibly targeting endothelial antigens. Neutrophils recruited by IL-17A in this process may enhance tissue damage by extensive NET formation (NETosis). Thus, the IL-23/IL-17 axis presumably controls neutrophilic inflammation in BD vasculitis in the context of a predominant antigen-specific CD8+ T-cell response.

1 January 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
AOAyse Oktem
Ayse Oktem
PUPınar Incel Uysal
Pınar Incel Uysal
NANeslihan Akdogan
Neslihan Akdogan
ATAslı Tokmak
Aslı Tokmak
BYBasak Yalcin
Basak Yalcin
Palmoplantar pustulosis is a chronic and relapsing disease of the palms and soles, which is characterized by scattered clusters of pinhead-sized, sterile pustules. The aim of the present study was to determine demographic features, co-morbidities, and relation of palmoplantar pustulosis with psoriasis. A total of 48 patients (M/F: 15/33) were enrolled in the present study. A detailed history regarding age of onset, palmoplantar pustulosis duration, number of recurrences, personal and family history of psoriasis, accompanying arthritis, sternoclavicular tenderness, dental fillings, smoking status, and autoimmune disease was obtained; thorough dermatological examination was carried out. Patch testing results and laboratory investigations for thyroid autoimmunity were recorded. Thirty-five of 48 patients (72.9%) were current smokers. Twenty of the 48 patients (41.7%) had dental fillings. There was not any significant correlation between palmoplantar pustulosis duration and dental filling duration (p=0.170). Psoriasis was not detected in any patients either in history or in dermatological examination. Nail involvement and joint complaints were observed in seven of 48 patients (14%) and in nine of 48 patients (18%), respectively. Autoimmune thyroiditis was observed in four of 48 patients (12%). Patients with patch testing positivity (12.5% of patients, M/F: 1/5) had no considerable association for history of external contact with these materials. Retrospective analysis. Palmoplantar pustulosis appears to be a distinct entity from psoriasis. Routine thyroid functions test could be analyzed, but patch testing is not required in patients with palmoplantar pustulosis. Also, patients with palmoplantar pustulosis must be evaluated for musculoskeletal symptoms and signs.

28 October 2022 in Clinical and Experimental Dermatology
Verified
Journal Article
Open access
PDF file
AOAyse Oktem
Ayse Oktem
GRGunel Rasulova
Gunel Rasulova
BCBusra Cavdarli
Busra Cavdarli
SBSeher Bostanci
Seher Bostanci
AHAylin Heper
Aylin Heper
SVSeçil Vural
Seçil Vural
Autoinflammatory diseases of the skin are a complex group of disorders. In recent years, hidradenitis suppurativa (HS) and porokeratosis have been classified as autoinflammatory keratinization diseases.1,2